<DOC>
	<DOC>NCT00309543</DOC>
	<brief_summary>This clinical investigation examined the influence of cytostatic chemotherapy with 5-fluorouracil, modulated by biologically active leucovorin, on patientsâ€™ survival time following surgery for colon carcinoma Stage II.</brief_summary>
	<brief_title>Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B</brief_title>
	<detailed_description />
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Patients with histologically verified, operable colon carcinoma Stage II (RO, T34, N0, M0) Age: less than 80 years WHO Performance &gt; 2 Adequate bone marrow reserve, renal and hepatic functions Informed consent Rectal cancer R1or R2 resection; carcinosis peritonei Start of treatment &gt; 42 days postop; other adjuvant radiotherapy, chemotherapy or immunotherapy Serious concomitant disease, in particular chronically inflammatory large intestine, cardiopathic or metabolic disease, malignant second carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Fluorouracil</keyword>
	<keyword>Leucovorin</keyword>
	<keyword>Colon cancer</keyword>
</DOC>